Published in AIDS Weekly, August 28th, 2000
The most important criterion for awarding this type of contract is technical quality, followed by reasonable pricing. The contract includes VircoGEN II tests, Virco's genotypic resistance test that identifies mutations in the genetic code of HIV that cause drug resistance, and Antivirogram phenotypic tests, which measure the ability of the virus to grown in the presence of each of the drugs in the laboratory.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.